DE3679781D1 - Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung. - Google Patents

Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.

Info

Publication number
DE3679781D1
DE3679781D1 DE8686116096T DE3679781T DE3679781D1 DE 3679781 D1 DE3679781 D1 DE 3679781D1 DE 8686116096 T DE8686116096 T DE 8686116096T DE 3679781 T DE3679781 T DE 3679781T DE 3679781 D1 DE3679781 D1 DE 3679781D1
Authority
DE
Germany
Prior art keywords
prophylaxis
compositions
treatment
epithelial destruction
epithelial
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8686116096T
Other languages
English (en)
Inventor
Eeva-Marjatta Salonen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Santen Pharmaceutical Co Ltd
Original Assignee
Huhtamaki Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Huhtamaki Oyj filed Critical Huhtamaki Oyj
Application granted granted Critical
Publication of DE3679781D1 publication Critical patent/DE3679781D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
DE8686116096T 1985-11-22 1986-11-20 Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung. Expired - Fee Related DE3679781D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI854634A FI854634A0 (fi) 1985-11-22 1985-11-22 Foerfarande foer bestaemning av proteolytisk aktivitet.

Publications (1)

Publication Number Publication Date
DE3679781D1 true DE3679781D1 (de) 1991-07-18

Family

ID=8521732

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8686116096T Expired - Fee Related DE3679781D1 (de) 1985-11-22 1986-11-20 Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.

Country Status (6)

Country Link
US (1) US4849406A (de)
EP (1) EP0223254B1 (de)
JP (2) JPH0772139B2 (de)
AU (1) AU591199B2 (de)
DE (1) DE3679781D1 (de)
FI (1) FI854634A0 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS275231B2 (en) * 1989-09-29 1992-02-19 Ustav Makormolekularni Chemie Medicine bottle
FI895671A (fi) * 1989-11-27 1991-05-28 Labsystems Oy Skyddande av intraokulaera strukturer.
US5354269A (en) * 1991-12-20 1994-10-11 Fibrogenex, Inc. Method for treating cancer resections
GB2271507A (en) * 1992-09-04 1994-04-20 Summit Technology Ireland Bv Compositions containing plasmin activity inhibitors
SE470477B (sv) * 1992-10-05 1994-05-24 Procell Bioteknik Ab Salva innehållande fibronektin för behandling av sår
EP1060748A4 (de) * 1998-02-25 2002-09-04 Wakamoto Pharma Co Ltd Medikamente für corneaepithelstörungen
JP4313033B2 (ja) * 2002-12-27 2009-08-12 株式会社日本点眼薬研究所 眼科用治療組成物
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
US20090131303A1 (en) * 2007-11-16 2009-05-21 Bor-Shyue Hong Methods and compositions for treating dry eye

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276284A (en) * 1971-07-26 1981-06-30 Brown Stuart I Prevention of collagenase induced disease by treatment with collagenase inhibitors
US4171377A (en) * 1978-08-11 1979-10-16 Burton, Parsons & Co., Inc. Ophthalmic solution of tranexamic acid
AT359653B (de) * 1979-02-15 1980-11-25 Immuno Ag Verfahren zur herstellung eines gewebekleb- stoffes
JPS5699427A (en) * 1980-01-11 1981-08-10 Green Cross Corp:The Human urine trypsin inhibitor derivative and its preparation
JPS56147718A (en) * 1980-04-16 1981-11-16 Sumitomo Chem Co Ltd Acidic protease inhibitor and antiulcerative composed thereof
JPS57144224A (en) * 1981-03-02 1982-09-06 Mochida Pharmaceut Co Ltd Remedy for respiratory dieseases
ATE13810T1 (de) * 1981-06-25 1985-07-15 Serapharm Gmbh & Co Kg Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundabdeckung.
DE3211254A1 (de) * 1982-03-26 1983-09-29 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zum nachweis des vorliegens einer allergie und zum spezifischen nachweis des fuer die allergie verantwortlichen allergens
JPS59155324A (ja) * 1983-02-24 1984-09-04 Zeria Shinyaku Kogyo Kk ヒト尿中チオ−ルプロテア−ゼインヒビタ−を有効成分とする抗炎症剤及びその製造法
AU560584B2 (en) * 1983-07-28 1987-04-09 Bayer Aktiengesellschaft Homologues of aprotinin
EP0189784B1 (de) * 1985-01-18 1989-11-08 G.D. Searle & Co. Menschlicher, natürlicher Collagenaseninhibitor

Also Published As

Publication number Publication date
JPS62187413A (ja) 1987-08-15
EP0223254A2 (de) 1987-05-27
FI854634A0 (fi) 1985-11-22
AU6560486A (en) 1987-05-28
JPH0772139B2 (ja) 1995-08-02
JP2596526B2 (ja) 1997-04-02
JPH08110337A (ja) 1996-04-30
EP0223254B1 (de) 1991-06-12
AU591199B2 (en) 1989-11-30
EP0223254A3 (en) 1989-01-25
US4849406A (en) 1989-07-18

Similar Documents

Publication Publication Date Title
DE3579113D1 (de) Zusammensetzungen zur milderung, behandlung und bestimmungung von arthritschen krankheiten und aehnlichen zustaenden.
DE3583392D1 (de) Carbonatapatit enthaltendes mittel und die verwendung von carbonatapatit fuer implantate.
DE68929554D1 (de) Piperazinyl-substituierte Phenylpyrimidinderivative zur Behandlung oder Vorbeugung von ZNS Erkrankungen
DE69002057D1 (de) Reaktor fuer die behandlung von fluessigem kakao und seinen derivaten.
DE69024039T2 (de) Behandlung von pathologischen zuständen und krankheiten.
DE3685633D1 (de) Behandlung von knochenstoerungen.
DE3667605D1 (de) Windel zur verhuetung von wundliegen.
KR880700673A (ko) 골손상 치료용방법 및 조성물
DE3672283D1 (de) Konditionierungsmittel fuer die behandlung von basismaterialien.
DE3850433T2 (de) Allergiebehandlung und Zusammensetzung dafür.
DE3679781D1 (de) Verwendung von zusammensetzungen fuer die behandlung und die prophylaxe von epithelialer zerstoerung.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DE3686019D1 (de) Die verwendung von nitrofurantoin zur behandlung und verhuetung von magen-darmkrankheiten.
DE69004451T2 (de) Prophylaxe und Behandlung von Herpesvirus-Infektionen.
DE3586420T2 (de) Verwendung von dihydropyridinen zur behandlung und praevention von arteriosklerose.
DE68907569T2 (de) Mittel zur Behandlung oder Vorbeugung von Aids.
PT77020A (de) Mittel zur behandlung von wunden
DE3668116D1 (de) Zusammensetzung zur behandlung von infektionen.
DE3881377T2 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
DE69117566D1 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen
DE3667518D1 (de) Behandlung von archivmaterial.
NO862454L (no) Fremgangsmaate for behandling av peroxydblekeavluter.
ATE64861T1 (de) Carbonatapatit enthaltendes mittel und die verwendung von carbonatapatit fuer implantate.
KR900007413A (ko) 에이즈 발병방지, 치료제 및 그 치료용 조성물
ATE63457T1 (de) Arzneimittel zur behandlung und prophylaxe von leber- und nierenkrankheiten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: SANTEN OY, TAMPERE, FI

8327 Change in the person/name/address of the patent owner

Owner name: SANTEN PHARMACEUTICAL CO., LTD, OSAKA, JP

8328 Change in the person/name/address of the agent

Representative=s name: VOSSIUS & PARTNER, 81675 MUENCHEN

8339 Ceased/non-payment of the annual fee